Year |
Citation |
Score |
2022 |
Cheruku RR, Turowski SG, Durrani FA, Tabaczynski WA, Cacaccio J, Missert JR, Curtin L, Sexton S, Alberico R, Hendler CM, Spernyak JA, Grossman Z, Pandey RK. Tumor-Avid 3-(1'-Hexyloxy)ethyl-3-devinylpyrpyropheophorbide-a (HPPH)-3Gd(III)tetraxetan (DOTA) Conjugate Defines Primary Tumors and Metastases. Journal of Medicinal Chemistry. PMID 35763292 DOI: 10.1021/acs.jmedchem.2c00547 |
0.358 |
|
2022 |
Sokolow GE, Crawley MR, Morphet DR, Asik D, Spernyak JA, McGray AJR, Cook TR, Morrow JR. Metal-Organic Polyhedron with Four Fe(III) Centers Producing Enhanced T Magnetic Resonance Imaging Contrast in Tumors. Inorganic Chemistry. 61: 2603-2611. PMID 35073060 DOI: 10.1021/acs.inorgchem.1c03660 |
0.324 |
|
2020 |
Zhang S, Cheruku R, Dukh M, Tabaczynski W, Patel N, White W, Missert JR, Spernyak JA, Pandey RK. The structure of Gd(III) chelates conjugated at the periphery of 3-(1'-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) make significant impact in imaging and therapy of cancer. Chemmedchem. PMID 32916033 DOI: 10.1002/cmdc.202000449 |
0.374 |
|
2020 |
Rajab Bolookat E, Malhotra H, Rich LJ, Sexton S, Curtin L, Spernyak JA, Singh AK, Seshadri M. Development and Validation of a Clinically Relevant Workflow for MR-Guided Volumetric Arc Therapy in a Rabbit Model of Head and Neck Cancer. Cancers. 12. PMID 32121562 DOI: 10.3390/Cancers12030572 |
0.308 |
|
2014 |
Kalra AV, Spernyak J, Kim J, Sengooba A, Klinz S, Paz N, Cain J, Kamoun W, Straubinger N, Qu Y, Trueman S, Bayever E, Nielsen U, Drummond D, Fitzgerald J, et al. Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI) Cancer Research. 74: 2065-2065. DOI: 10.1158/1538-7445.Am2014-2065 |
0.345 |
|
2013 |
Portwood S, Lal D, Schaefer CW, Uwazurike O, Spernyak JA, Seshadri M, Wang ES. Potent Effects Of The Vascular Disrupting Agent, ASA404 (DMXAA) On The Marrow Microenvironment In Preclinical Human Leukemia and Lymphoma Models Blood. 122: 3953-3953. DOI: 10.1182/BLOOD.V122.21.3953.3953 |
0.315 |
|
2011 |
Sen A, Capitano ML, Spernyak JA, Schueckler JT, Thomas S, Singh AK, Evans SS, Hylander BL, Repasky EA. Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Research. 71: 3872-80. PMID 21512134 DOI: 10.1158/0008-5472.Can-10-4482 |
0.301 |
|
2010 |
Spernyak JA, White WH, Ethirajan M, Patel NJ, Goswami L, Chen Y, Turowski S, Missert JR, Batt C, Mazurchuk R, Pandey RK. Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy. Bioconjugate Chemistry. 21: 828-35. PMID 20387862 DOI: 10.1021/Bc9005317 |
0.367 |
|
2005 |
Bouvet M, Spernyak J, Katz MH, Mazurchuk RV, Takimoto S, Bernacki R, Rustum YM, Moossa AR, Hoffman RM. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Research. 65: 9829-33. PMID 16267005 DOI: 10.1158/0008-5472.Can-05-1548 |
0.331 |
|
2005 |
Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4241-50. PMID 15930363 DOI: 10.1158/1078-0432.Ccr-04-2703 |
0.346 |
|
2005 |
Mazurchuk R, Spernyak JA. Magnetic resonance imaging of tumor response to chemotherapy. Methods in Molecular Medicine. 111: 381-415. PMID 15911992 DOI: 10.1385/1-59259-889-7:381 |
0.315 |
|
2005 |
Li G, Slansky A, Dobhal MP, Goswami LN, Graham A, Chen Y, Kanter P, Alberico RA, Spernyak J, Morgan J, Mazurchuk R, Oseroff A, Grossman Z, Pandey RK. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjugate Chemistry. 16: 32-42. PMID 15656573 DOI: 10.1021/Bc049807X |
0.394 |
|
Show low-probability matches. |